Only a few cases of submucosally invasive colorectal cancer (SM-CRC) in diminutive colorectal polyps of ≤ 5 mm have been described [1] , and as yet there is no detailed knowledge of these cancers. Pathological SM-CRCs were selected from our colonoscopy database. We examined the frequency of these lesions relative to all colonoscopy examinations and to colorectal neoplasms ≤ 5 mm. The growth type of the lesions was divided into two categories: polypoid growth and non-polypoid growth [2] . A total of 32 692 colonoscopies were performed between September 2002 and December 2012, from which 5690 colorectal neoplasms were detected and treated. Only seven cases of SM-CRC occurred in lesions ≤ 5 mm, accounting for only 0.5 % (7/1358) of colorectal neoplasms ≤ 5 mm. Baseline patient information, endoscopic and pathological findings, and outcomes are summarized in • " Table 1 . Four cases were of protruded type and three cases were of depressed type. All the protruded-type lesions were initially diagnosed before treatment as being adenomas and were resected endoscopically. All the depressed-type lesions were diagnosed before treatment as being malignant. Endoscopic treatment was indicated for six of the patients (#1 -#6), and additional surgery was performed for two patients (#1 and #2) because of histological findings that suggested a high metastatic risk. All cases were of pathologically welldifferentiated adenocarcinomas of nonpolypoid growth type. No lymph node metastasis was evident in the surgically resected cases. The appearances in patients #2 and #3 are shown in • " Fig. 1 and• " Fig. 2 respectively. The most important finding of the present study was that all diminutive SM-CRCs were pathologically diagnosed as being of non-polypoid growth type. Shimoda et al. [2] reported that colorectal cancers showing non-polypoid growth tended to in-vade the submucosa when of a smaller size than those showing polypoid growth. Chromoendoscopy, magnified endoscopy, and image-enhanced endoscopy have been shown to be effective for the precise diagnosis of invasion depth in colorectal cancers [3, 4] . Careful endoscopic observation is strongly recommended when adopting the policies of the DISCARD trial [5, 6] .
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